Substrate binding to cytochromes P450

被引:0
作者
Emre M. Isin
F. Peter Guengerich
机构
[1] AstraZeneca R & D Mölndal,Biotransformation Section, Department of Discovery DMPK & Bioanalytical Chemistry
[2] Vanderbilt University School of Medicine,Department of Biochemistry and Center in Molecular Toxicology
来源
Analytical and Bioanalytical Chemistry | 2008年 / 392卷
关键词
Substrate binding; Cytochrome P450; Cooperativity; Ligands; Drug development;
D O I
暂无
中图分类号
学科分类号
摘要
P450s have attracted tremendous attention owing to not only their involvement in the metabolism of drug molecules and endogenous substrates but also the unusual nature of the reaction they catalyze, namely, the oxidation of unactivated C–H bonds. The binding of substrates to P450s, which is usually viewed as the first step in the catalytic cycle, has been studied extensively via a variety of biochemical and biophysical approaches. These studies were directed towards answering different questions related to P450s, including mechanism of oxidation, substrate properties, unusual substrate oxidation kinetics, function, and active-site features. Some of the substrate binding studies extending over a period of more than 40 years of dedicated work have been summarized in this review and categorized by the techniques employed in the binding studies.
引用
收藏
相关论文
共 700 条
[1]  
Guengerich FP(1994)undefined Toxicol Lett 70 133-138
[2]  
Denisov IG(2005)undefined Chem Rev 105 2253-2277
[3]  
Makris TM(2008)undefined Chem Res Toxicol 21 70-83
[4]  
Sligar SG(2006)undefined Drug Dev Res 66 19-24
[5]  
Schlichting I(1996)undefined Pharmacogenetics 6 1-42
[6]  
Guengerich FP(1968)undefined J Biol Chem 243 3543-3546
[7]  
Lewis DFV(1976)undefined Proc Natl Acad Sci USA 73 1078-1082
[8]  
Ito Y(1972)undefined J Biol Chem 247 5777-5784
[9]  
Goldfarb PS(1992)undefined FASEB J 6 674-679
[10]  
Nelson DR(1984)undefined Acc Chem Res 17 9-16